Effect of 3 to 5 Years of Scheduled CEA and C...

Long COVID is a debilitating condition impacting millions of people around the world, but is still poorly understood, poorly defined, and poorly treated. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, discusses long COVID with Wes Ely, MD, MPH, professor of me ...  Show more

Medicaid provides health insurance for 1 in 5 Americans and plays a crucial role in US health care infrastructure. The One Big Beautiful Bill Act (OBBBA) is estimated to cut Medicaid spending by nearly $1 trillion by 2034 and cause millions of enrollees to lose coverage. In this ...  Show more

In this episode, Dr Parveen Boora discusses colorectal cancer. Topics covered include: the epidemiology and natural history of colorectal cancer rationale of screening programs signs and symptoms of the disease history and physical exam findings leading to diagnosis staging and t ...  Show more

Dr. Refky Nicola speaks with Dr. Perry Pickhardt about his study comparing CT colonography and multi-targeted stool DNA testing for colorectal cancer screening. They explore differences in sensitivity, specificity, cost-effectiveness, and strategies to optimize detection while mi ...  Show more

Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner. 

¹⁸F-DCFPyL PET/CT for Initially Diagnosed and Biochem ...

Dr. Refky Nicola discusses Y-90 radioembolization for patients with metastatic colorectal cancer with Dr. Daniel Brown.  Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry. Emmons et al. Radiology 2022; 305:228– ...  Show more